Apr 8 |
SAB Biotherapeutics to Present at INNODIA Annual Meeting
|
Apr 4 |
SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference
|
Apr 1 |
SAB Biotherapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|
Mar 29 |
SAB Biotherapeutics GAAP EPS of -$7.64 misses by $3.43, revenue of $2.24M beats by $1.12M
|
Mar 29 |
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
|
Mar 25 |
SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment
|
Feb 23 |
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference
|
Feb 8 |
SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Feb 2 |
SAB Biotherapeutics announces Samuel J. Reich as CEO
|
Feb 2 |
SAB Biotherapeutics Announces Executive Leadership Change
|